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1. Introduction 
The structural integrity of the collagen fibril and 
possibly the catabolism of the collagen molecule is 
determined to a large extent by the type and density 
of collagen intermolecular cross links. The major 
intermolecular cross links in type I collagen are those 
derived from lysine residues [ 1 ] . There are two 
structural requirements necessary for the formation 
of this type of cross link. First, the presence of a 
lysine or hydroxylysine residue in the N and/or C 
non-triple helical regions of collagen which have been 
enzymatically converted to an aldehyde form. Second, 
a lysine or hydroxylysine residue present in the triple 
helical region of the molecule in a position such that 
it aligns with the above described aldehyde when the 
molecules are in a quarter staggered arrangement as 
found in collagen fibrils [2]. 
The discovery of type III collagen presented, for 
the first time, a situation in which two types of 
collagen (types I and III), exhibiting different macro- 
molecular organisations, are found in close association 
in the same tissue [3]. It has been established that, 
unlike type I, type III collagen contains cysteine 
residues which form interchain disulphide cross links 
[4]. Type III collagen in adult tissues is insoluble, 
but can be extracted from pepsin solubilised material. 
As the cysteine cross links are still present in pepsin 
solubilised type III collagen, this indicates that, like 
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type I, the N- and C-terminal non-triple helical 
extensions of type III collagen also contain cross 
link sites that are removed by pepsin treatment. 
It is known that the triple helical sequence of 
type I collagen has two regions, each of which 
contains a hydroxylysine residue, that are involved 
in the intermolecular cross link formation [2,5,6]. 
Recently, identical sequences in corresponding 
regions of the triple helix of type III collagen have 
been found [7] and therefore one requirement for 
the formation of lysine derived cross links in type III 
collagen is established. The second requirement, the 
presence of a lysine residue in the N and C terminal 
non-triple helical regions of type III collagen, has 
been indicated from amino acid analysis data [8]. 
In this publication the sequence of the N-terminal 
non-triple helical region of type III fetal calf skin 
collagen is described. The N-terminal cyanogen 
bromide peptide CB3A was isolated and cleaved with 
a protease from Stuphylococc~s aureus, chymotrypsin 
and trypsin. The peptides containing non-triple 
helical sequences were isolated using molecular sieve 
chromatography and sequenced. The N-terminal of 
CB3A was blocked, probably by a pyroglutamic 
acid residue. The non-triple helical sequence was found 
to be 14 residues long and has similar characteristics 
to that of type I collagen. It has a high content of 
hydrophobic amino acid residues, contains two 
tyrosine residues which are important components of 
type III collagen antigenic determinants [9] and has 
a lysine residue, a possible site for intermolecular 
cross link formation. Evidence indicating that the 
lysine residue is a site for intermolecular cross linking 
formation is discussed. 
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2. Methods I II’ 
2.1. Peptide CB3A 
Peptide CB3A was prepared from cyanogen 
bromide digests of type III collagen from fetal calf 
skin as recently described [8]. 
2.2. Staphylococcal protease digestion of CB3A 
Staphylococcal protease digestion of CB3A was 
carried out in 0.2 M NH4HC03-HCl buffer pH 7.8 
[lo] . The enzyme (protease from Staphylococcus 
aureus, strain V8, Miles Labs., England) was added to 
the peptide dissolved in buffer (3 mg/ml) to give an 
enzyme to substrate ratio of 1:30. Incubation at 37°C 
was continued for 16 h and then the mixture applied 
directly to a column of Sephadex G-50 superfine 
(2 X 150 cm) equilibrated at room temperature with 
0.2 M NHdHCOJ solution at a flow rate of 18 ml/h. 
I 
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Fig.1, Molecular sieve chromatography of the staphylococcal 
protease digest of CB3A (9 mg) on a Sephadex G-50 super- 
tine. The column (2 X 150 cm) was equilibrated, at room 
temperature, with a 0.2 M NH,HCO, solution at a flow rate 
of 18 ml/h. 
2.3. Trypsin and chymotrypsin digestion of CB3A 3. Results and discussion 
Trypsin and chymotrypsin digestion of CB3A and 
separation of the products was carried out as 
described above for the staphylococcal protease but 
using enzyme to substrate ratios of 1 : 50 and 
1 : 200 and incubation times of 4 h and 1 h respec- 
tively (Trypsin: Worthington Biochem. Corp. TPCK- 
trypsin 212 U/mg. Chymotrypsin: Worthington 
Biochem. Corp., cu-chymotrypsin 50 U/mg). 
Initial attempts to sequence intact CB3A failed 
because the N-terminal was blocked, probably by a 
pyroglutamic acid residue as is the case for type I 
collagen a-chains. This made it necessary to degrade 
the peptide in order to produce fragments that could 
be sequenced. 
Small peptides from the Sephadex C-50 superfine 
separations were rechromatographed on a column 
(2.8 X 105 cm) of Bio-Gel P2 (Bio Rad 200-400 
mesh) equilibrated at room temperature with 1% 
acetic acid at a flow rate of 20 ml/h. 
Staphylococcal protease, under the conditions 
used, cleaves specifically on the C-terminal side of 
glutamic acid residues. Digestion of CB3A with this 
enzyme and separation of the products, produced the 
peptide pattern shown in fig.1. Fraction a was shown, 
by amino acid composition and N-terminal sequence 
analysis, to contain the same material as fraction b*. 
2.4. Sequence analysis 
Sequence analysis was carried out automatically in 
a liquid phase sequencer (model 890 from Beckmann 
Instruments, Palo Alto, Calif. USA). Experimental 
details were recently described elsewhere [ 111. PTH 
derivatives were identified by thin layer chromato- 
graphy and gas-liquid chromatography. 
Fraction b was lyophylised, sequenced and was 
found to contain a peptide (fig.2, SP 2) with a N- 
terminal non-triple helical extension of 12 residues. 
From the 13th residue onwards it was identical to the 
known sequence of peptide CB3A, isolated from 
2.5. Amino acid analysis 
Amino acid analysis of peptide hydrolysates 
(6 N HCl, 110 for 24 h under Nz) were carried out on 
a Durrum D 500 analyser (Palo Alto, Calif. USA). 
* Peptides Tl, Cl and intact CB3A isolated from salt soluble 
and pepsin solubilised type III collagen, all chromato- 
graphed as two peaks. However, when chromatography was 
carried out using sodium acetate buffer instead of 
ammonium bicarbonate these peptides chromatographed 
as single peaks. It appeared that the peptides aggregated in 
ammonium bicarbonate buffer and that the aggregation 
was not caused by the non-triple helical sequences. 
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Fig.2. Amino acid sequence of the N terminal region of or1 (III) from fetal calf skin collagen and for comparison the N terminal 
region of (~1 (I) from calf skin collagen [ 21. The sequences are aligned so that there is maximum homology between the triple 
helical regions of the chains (not shown). The rows of arrows (--7) indicate the residues sequenced in the peptide indicated to 
their right. The lower schematic representation of the or1 (III) sequence shown, indicates the cleavage points of the enzymes used. 
the designations of the peptides so produced and in brackets the number of amino acid residues per peptide. The enzymes used 
were: staphylococcal protease (SP), trypsin (T), chymotrypsin (C). 
pepsin solubilised type III collagen [ 121 . Fraction c 
(fig.1) contained a peptide from the C-terminal 
triple helical region of CB3A whose sequence is 
known [ 121 . Fraction d (lig.1) from its amino acid 
analysis and size, appeared to be a tripeptide (Tyr, 
GlX2) (fig.2 SP 1). From the specificity of the 
staphylococcal protease used, Glu was expected to 
be at the C-terminal of the tripeptide and because 
CB3A was blocked, pyroglutamic acid at its N- 
terminal. The deduced sequence was therefore 
<Glu-Tyr-Glu. This is in agreement with other 
recently published data [ 141 . 
The complete sequence as shown in fig.2 was 
confirmed by sequencing the largest peptides produced 
by the chymotrypsin and trypsin digestion of CB3A 
(fig.2, peptides Cl and Tl respectively). The N- 
terminal peptides T 0 and C 0 were also isolated and 
characterised by amino acid analysis in order to 
confirm the composition and size of SP 1. 
sequences of the al (I) and cwl (III) chains shown 
in fig.2 are aligned so’ that there is maximum 
homology between the N-terminal triple helical 
regions of the (Y chains. This alignment was established 
from electron microscope studies of the cross 
striation banding patterns of segment long spacing 
crystallites and sequence data of each chain [ 121. 
Using this alignment it can be seen that the ~rl (III) 
chain is two triplets longer at its N-terminal than the 
oil (I) chain. There are 14 N-terminal non-triple 
helical residues as compared to 16 found in type 1 
collagen from calf skin (fig.2). The cleavage site for 
pepsin is a Gly-Ile bond. The non-triple helical 
extension of type III collagen exhibits the same 
characteristics as that of type I collagen. Both 
contain two tyrosine residues which are responsible 
for the high antigenicity of these regions [9,13], and 
both have a high content of hydrophobic amino acid 
residues. 
Elucidation of the non-triple helical sequence As in all other N-terminal non-triple helical 
revealed that the first two residues of pepsin solubilis- extensions that have been characterised, the type III 
ed type III collagen, Be-Ala, are in fact part of the extension contains a lysine residue. It is the 8th 
first triplet of the triple helix. The N-terminal residue from the N-terminal and is not hydroxylated. 
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Although evidence for the presence of a lysine 
derived aldehyde (allysine) was not found in these 
studies, trypsin digests of insoluble calf skin have 
been found to contain a cross linked peptide from 
the N-terminal region of type III collagen, in which 
lysine is present presumably in the form of an aldol 
condensation product [ 141. The requirements for 
lysine derived intermolecular cross link formation are 
therefore present in type III collagen. The N-terminal 
intermolecular cross link formed would be between 
allysine in the non-triple helical extention and 
hydroxylysine in the triple helical region giving rise 
to the acid labile dehydro-hydroxylysino-norleucine 
cross link. This assumes that the extracted type III 
collagen is representative of the whole type III col- 
lagen content of the tissue. However, as salt soluble 
type III collagen represents less than 5% of the 
total type III collagen present in fetal calf skin, it 
is possible that the lysine in the N-terminal non-triple 
helical region of insoluble type III collagen is 
hydroxylated, giving rise to the more stable hydroxy- 
lysino-S-ketonorleucine intermolecular cross link. 
This would explain the apparently contradictory data 
recently published [ 15,161 concerning the identity 
of the intermolecular cross links in fetal calf skin 
collagen when identified using sodium borohydride 
reduction methods. 
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